Cargando…

General practitioners’ awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey

OBJECTIVES: In July 2017, UK National Institute for Health and Care Excellence (NICE) published a diagnostic guidance (DG30) recommending the use of faecal immunochemical tests (FITs) for symptomatic patients who do not meet the urgent referral pathway for suspected colorectal cancer (CRC). We asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Von Wagner, Christian, Stoffel, Sandro Tiziano, Freeman, Madeline, Laszlo, Helga E, Nicholson, Brian D, Sheringham, Jessica, Szinay, Dorothy, Hirst, Yasemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500239/
https://www.ncbi.nlm.nih.gov/pubmed/30975679
http://dx.doi.org/10.1136/bmjopen-2018-025737
_version_ 1783415910140215296
author Von Wagner, Christian
Stoffel, Sandro Tiziano
Freeman, Madeline
Laszlo, Helga E
Nicholson, Brian D
Sheringham, Jessica
Szinay, Dorothy
Hirst, Yasemin
author_facet Von Wagner, Christian
Stoffel, Sandro Tiziano
Freeman, Madeline
Laszlo, Helga E
Nicholson, Brian D
Sheringham, Jessica
Szinay, Dorothy
Hirst, Yasemin
author_sort Von Wagner, Christian
collection PubMed
description OBJECTIVES: In July 2017, UK National Institute for Health and Care Excellence (NICE) published a diagnostic guidance (DG30) recommending the use of faecal immunochemical tests (FITs) for symptomatic patients who do not meet the urgent referral pathway for suspected colorectal cancer (CRC). We assessed general practitioners’ (GP) awareness of DG30 in primary care 6 months after its publication. DESIGN AND SETTING: Cross-sectional online survey of GPs hosted by an English panel of Primary health care professionals. PARTICIPANTS: In December 2017, 1024 GPs registered on an online panel (M3) based in England took part in an online survey. OUTCOMES AND VARIABLES: We investigated a number of factors including previous experience of using FIT and guaiac faecal occult blood tests (FOBTs), the number of urgent referrals for CRC that GPs have made in the last year and their sociodemographic and professional characteristics that could be associated with their self-reported awareness of the FIT diagnostic guidance. RESULTS: Of the 1024 GPs who completed the survey, 432 (42.2%) were aware of the current recommendation but only 102 (10%) had used it to guide their referrals. Awareness was lowest in North West England compared with London (30.5% vs 44.9%; adjusted OR: 0.55, 95% CI 0.33 to 0.92). Awareness of the FIT guidance was positively associated with test usage after the NICE update (adjusted OR: 13.00, 95% CI 6.87 to 24.61) and having specialist training (adjusted OR: 1.48, 95% CI 1.05 to 2.08). The number of urgent referrals, the previous use of FOBt, GPs’ age and gender, work experience and practice size (both in terms of the number of GPs or patients at the practice) were not associated with awareness. CONCLUSIONS: Less than half of GPs in this survey recognised the current guidance on the use of FIT. Self-reported awareness was not systematically related to demographic of professional characteristics.
format Online
Article
Text
id pubmed-6500239
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65002392019-05-21 General practitioners’ awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey Von Wagner, Christian Stoffel, Sandro Tiziano Freeman, Madeline Laszlo, Helga E Nicholson, Brian D Sheringham, Jessica Szinay, Dorothy Hirst, Yasemin BMJ Open Diagnostics OBJECTIVES: In July 2017, UK National Institute for Health and Care Excellence (NICE) published a diagnostic guidance (DG30) recommending the use of faecal immunochemical tests (FITs) for symptomatic patients who do not meet the urgent referral pathway for suspected colorectal cancer (CRC). We assessed general practitioners’ (GP) awareness of DG30 in primary care 6 months after its publication. DESIGN AND SETTING: Cross-sectional online survey of GPs hosted by an English panel of Primary health care professionals. PARTICIPANTS: In December 2017, 1024 GPs registered on an online panel (M3) based in England took part in an online survey. OUTCOMES AND VARIABLES: We investigated a number of factors including previous experience of using FIT and guaiac faecal occult blood tests (FOBTs), the number of urgent referrals for CRC that GPs have made in the last year and their sociodemographic and professional characteristics that could be associated with their self-reported awareness of the FIT diagnostic guidance. RESULTS: Of the 1024 GPs who completed the survey, 432 (42.2%) were aware of the current recommendation but only 102 (10%) had used it to guide their referrals. Awareness was lowest in North West England compared with London (30.5% vs 44.9%; adjusted OR: 0.55, 95% CI 0.33 to 0.92). Awareness of the FIT guidance was positively associated with test usage after the NICE update (adjusted OR: 13.00, 95% CI 6.87 to 24.61) and having specialist training (adjusted OR: 1.48, 95% CI 1.05 to 2.08). The number of urgent referrals, the previous use of FOBt, GPs’ age and gender, work experience and practice size (both in terms of the number of GPs or patients at the practice) were not associated with awareness. CONCLUSIONS: Less than half of GPs in this survey recognised the current guidance on the use of FIT. Self-reported awareness was not systematically related to demographic of professional characteristics. BMJ Publishing Group 2019-04-11 /pmc/articles/PMC6500239/ /pubmed/30975679 http://dx.doi.org/10.1136/bmjopen-2018-025737 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Diagnostics
Von Wagner, Christian
Stoffel, Sandro Tiziano
Freeman, Madeline
Laszlo, Helga E
Nicholson, Brian D
Sheringham, Jessica
Szinay, Dorothy
Hirst, Yasemin
General practitioners’ awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey
title General practitioners’ awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey
title_full General practitioners’ awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey
title_fullStr General practitioners’ awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey
title_full_unstemmed General practitioners’ awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey
title_short General practitioners’ awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey
title_sort general practitioners’ awareness of the recommendations for faecal immunochemical tests (fits) for suspected lower gastrointestinal cancers: a national survey
topic Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500239/
https://www.ncbi.nlm.nih.gov/pubmed/30975679
http://dx.doi.org/10.1136/bmjopen-2018-025737
work_keys_str_mv AT vonwagnerchristian generalpractitionersawarenessoftherecommendationsforfaecalimmunochemicaltestsfitsforsuspectedlowergastrointestinalcancersanationalsurvey
AT stoffelsandrotiziano generalpractitionersawarenessoftherecommendationsforfaecalimmunochemicaltestsfitsforsuspectedlowergastrointestinalcancersanationalsurvey
AT freemanmadeline generalpractitionersawarenessoftherecommendationsforfaecalimmunochemicaltestsfitsforsuspectedlowergastrointestinalcancersanationalsurvey
AT laszlohelgae generalpractitionersawarenessoftherecommendationsforfaecalimmunochemicaltestsfitsforsuspectedlowergastrointestinalcancersanationalsurvey
AT nicholsonbriand generalpractitionersawarenessoftherecommendationsforfaecalimmunochemicaltestsfitsforsuspectedlowergastrointestinalcancersanationalsurvey
AT sheringhamjessica generalpractitionersawarenessoftherecommendationsforfaecalimmunochemicaltestsfitsforsuspectedlowergastrointestinalcancersanationalsurvey
AT szinaydorothy generalpractitionersawarenessoftherecommendationsforfaecalimmunochemicaltestsfitsforsuspectedlowergastrointestinalcancersanationalsurvey
AT hirstyasemin generalpractitionersawarenessoftherecommendationsforfaecalimmunochemicaltestsfitsforsuspectedlowergastrointestinalcancersanationalsurvey